Keith Katkin

Affiliations

  • Director at Emergent Biosolutions Inc. (EBS), 2025-05-28
  • at Syndax Pharmaceuticals Inc (SNDX), 2025-05-19
  • at Eledon Pharmaceuticals Inc. (ELDN), 2025-01-13
  • Director at Rigel Pharmaceuticals Inc (RIGL), 2021-05-22
  • Peo;Ceo/Urovant Sciences, Inc. at Urovant Sciences Ltd. (UROV), 2020-02-21
  • Director at Carbylan Therapeutics Inc. (CBYL), 2015-08-05
  • President And Ceo at Avanir Pharmaceuticals Inc. (AVNR), 2014-12-18
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SNDX $9.11 10,000 $91,120.00 100,000 2025-05-19 Filing
AVNR $2.61 10,000 $26,093.00 327,857 2012-03-06 Filing
AVNR $0.44 14,100 $6,204.00 593,442 2009-02-24 Filing
AVNR $0.43 900 $387.00 579,342 2009-02-24 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EBS $6.30 7,844 $49,417.20 86,431 2025-05-23 Filing
SNDX $25.90 9,117 $236,138.51 32,000 2022-10-06 Filing
SNDX $25.90 20,782 $538,272.50 32,000 2022-10-06 Filing
SNDX $25.00 223 $5,575.00 32,000 2022-10-04 Filing
SNDX $25.00 137 $3,425.00 32,000 2022-10-04 Filing